Search Results - "Farrerons, J"

Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk by Boonen, S, Adachi, J. D, Man, Z, Cummings, S. R, Lippuner, K, Törring, O, Gallagher, J. C, Farrerons, J, Wang, A, Franchimont, N, San Martin, J, Grauer, A, McClung, M

“…Denosumab treatment for 3 years significantly reduced the incidence of new vertebral and hip fractures in women at higher risk for experiencing these…”
Get full text

Impact of 3-monthly vitamin D supplementation plus exercise on survival after surgery for osteoporotic hip fracture in adult patients over 50 years: A pragmatic randomized, partially blinded, controlled trial by Laiz, Ana, Malouf, J., Marin, A., Longobardi, V., de Caso, J., Farrerons, J., Casademont, J.

“…Objective To determine whether 3-monthly supplementation of an oral vitamin D widely used in Spain (calcifediol) plus daily exercise could influence survival…”
Get full text

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial by CAULEY, Jane A, NORTON, Larry, STEPAN, Jan J, POWLES, Trevor J, MORROW, Monica, COSTA, Alberto, SILFEN, Sheryl L, WALLS, Erin L, SCHMITT, Henry, MUCHMORE, Douglas B, JORDAN, V. Craig, LIPPMAN, Marc E, ECKERT, Stephen, KRUEGER, Kathryn A, PURDIE, David W, FARRERONS, Jordi, KARASIK, Avraham, MELLSTROM, Dan, NG, Kong Wah

“…Raloxifene, a selective estrogen receptor modulator approved for the prevention and treatment of postmenopausal osteoporosis, has shown a significant reduction…”
Get full text

Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females by Sucunza, N, Barahona, M J, Resmini, E, Fernández-Real, J M, Farrerons, J, Lluch, P, Puig, T, Wägner, A M, Ricart, W, Webb, S M

“…BackgroundAcromegaly changes body composition (BC), but long-term gender differences have not been reported.ObjectiveTo evaluate BC in active and controlled…”
Get full text

The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density by Stepan, J., Ish-Shalom, S., Hawkins, F., Marín, F., Farrerons, J., Kapetanos, G.

Get full text

PDB56 Development of a New Measure for Assessing Health Related Quality of Life (HRQOL) in Patients with Primary Hyperparathyroidism (PHPQoL) by Farrerons, J, Muñoz, M, Puig, M, Villabona, C, Webb, S, Badia, X

Get full text

Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers by Farrerons, J, Barnadas, M, Rodríguez, J, Renau, A, Yoldi, B, López-Navidad, A, Moragas, J

“…Some studies have suggested that the use of sunscreens to prevent skin cancer may put the population at risk of vitamin D deficiency. We followed 24 sunscreen…”
Get full text

OR7,3 Bone mineral density is a predictor of adiponectin and visfatin in patients with acromegaly by Sucunza, N, Resmini, E, Barahona, M.J, Fernández-Real, J.M, Ricart, W, Farrerons, J, Lluch, P, Webb, S.M

Get full text

Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial by Guañabens, N, Farrerons, J, Perez-Edo, L, Monegal, A, Renau, A, Carbonell, J, Roca, M, Torra, M, Pavesi, M

“…To compare the effects of sodium fluoride and etidronate in severe postmenopausal osteoporosis, we conducted a 3 year, prospective, trial in 118 postmenopausal…”
Get full text

The impact of high level basketball competition, calcium intake, menses, and hormone levels in adolescent bone density: a three-year follow-up by Bagur-Calafat, C, Farrerons-Minguella, J, Girabent-Farrés, M, Serra-Grima, J R

“…The main goal of the present work is to establish the positive influence high-impact physical exercise, specifically high-level basketball, on bone acquisition…”
Get full text

Yield point in prediction of compressive behavior of lumbar vertebral body by dual-energy x-ray absorptiometry by Renau, Antoni, Farrerons, J, Yoldi, B, Gil, J, Proubasta, I, Llauger, J, Oliván, J Gonzalez, Planell, J

“…The aims of the present study were to evaluate the influence of bone mineral content (BMC) and density on the behavior of the lumbar vertebra during…”
Get more information

Bone mass and mineral metabolism in kidney transplant patients by Renau, A, Yoldi, B, Farrerons, J, Solá, R, Guirado, L, Gich, I

Get full text

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment by Obermayer‐Pietsch, Barbara M, Marin, Fernando, McCloskey, Eugene V, Hadji, Peyman, Farrerons, Jordi, Boonen, Steven, Audran, Maurice, Barker, Clare, Anastasilakis, Athanasios D, Fraser, William D, Nickelsen, Thomas

“…Previous antiresorptive (AR) treatment may influence the response to teriparatide. We examined BMD response and safety in a subgroup of 503 postmenopausal…”
Get full text

Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS) by Eastell, Richard, Nickelsen, Thomas, Marin, Fernando, Barker, Clare, Hadji, Peyman, Farrerons, Jordi, Audran, Maurice, Boonen, Steven, Brixen, Kim, Gomes, Jose Melo, Obermayer‐Pietsch, Barbara, Avramidis, Avraam, Sigurdsson, Gunnar, Glüer, Claus C

“…It is unclear which treatment should be given after stopping teriparatide therapy for severe osteoporosis. In a prospective, randomized, controlled, 2‐yr…”
Get full text

Monitoring Teriparatide‐Associated Changes in Vertebral Microstructure by High‐Resolution CT In Vivo: Results From the EUROFORS Study by Graeff, Christian, Timm, Wolfram, Nickelsen, Thomas N, Farrerons, Jordi, Marín, Fernando, Barker, Clare, Glüer, Claus C

“…We introduce a method for microstructural analysis of vertebral trabecular bone in vivo based on HRCT. When applied to monitor teriparatide treatment, changes…”
Get full text

Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine by Sosa Henríquez, M, Díaz Curiel, M, Díez Pérez, A, Gómez Alonso, C, González Macías, J, Farrerons Minguella, J, Filgueira Rubio, J, Mellibovsky Saidler, L, Nogués Solán, X, Hernández Hernández, D

“…Our objective has been to elaborate an updated Clinical Guide of the Spanish Society of Internal Medicine (SEMI) for the prevention and treatment of…”
Get more information

Norfloxacin-induced hepatotoxicity by López-Navidad, A, Domingo, P, Cadafalch, J, Farrerons, J

Get more information

Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis by Recker, Robert R, Marin, Fernando, Ish‐Shalom, Sophia, Möricke, Rüdiger, Hawkins, Federico, Kapetanos, Georgios, de la Peña, María P, Kekow, Jörn, Farrerons, Jordi, Sanz, Beatriz, Oertel, Heide, Stepan, Jan

“…We assessed the effects on bone remodeling and histomorphometry after daily subcutaneous injections of teriparatide (n = 39, 20 μg/d) or oral strontium…”
Get full text

Sodium fluoride treatment is a major protector against vertebral and nonvertebral fractures when compared with other common treatments of osteoporosis: a longitudinal, observational study by Farrerons, J, Rodríguez de la Serna, A, Guañabens, N, Armadans, L, López-Navidad, A, Yoldi, B, Renau, A, Vaqué, J

“…In a 5-year observational study we have compared sodium fluoride (NaF) with different treatments commonly used in the treatment of osteoporosis: calcium,…”
Get full text

Risk factors for prediction of inadequate response to antiresorptives by Díez-Pérez, Adolfo, Olmos, Jose M, Nogués, Xavier, Sosa, Manuel, Díaz-Curiel, Manuel, Pérez-Castrillón, Jose Luis, Pérez-Cano, Ramon, Muñoz-Torres, Manuel, Torrijos, Antonio, Jodar, Esteban, Del Rio, Luis, Caeiro-Rey, Jose R, Farrerons, Jordi, Vila, Joan, Arnaud, Claude, González-Macías, Jesus

“…Some patients sustain fractures while on antiresorptives. Whether this represents an inadequate response (IR) to treatment or a chance event has not been…”
Get full text